FDA Says Lindane Remains Viable Lice Killer, Denies Ban Request
This article was originally published in The Rose Sheet
Executive Summary
FDA finds no reason why prescription lindane should be banned from use in lice/scabies treatments, as requested by the Natural Resources Defense Council. The Rx ingredient’s use, and associated adverse events, have declined over the years with tighter labeling requirements, the agency notes.